Over the past decade, the landscape of cancer research has undergone a remarkable transformation. Driven by rapid advancements in high-throughput omics technologies—encompassing genomics, transcriptomics, proteomics, and metabolomics—alongside sophisticated bioinformatics tools, researchers are unraveling the complex molecular networks underpinning cancer pathogenesis. These research efforts have not only deepened our understanding of the molecular drivers of malignancies but have also paved the way for new paradigms in early cancer detection, robust molecular classification schemes, and the development of highly individualized treatment strategies.
Despite these promising advances, several critical challenges persist in the effective translation of molecular discoveries into clinical practice. Among these are the identification of reliable biomarkers for early cancer detection or prognosis, resistance to targeted therapies, and the clinical implementation of innovative therapeutic platforms. Addressing these gaps requires the integration of basic, translational, and clinical research, as well as dialogue between academic, technological, and medical communities.
This Research Topic seeks to foster a comprehensive discussion encompassing the full spectrum of recent progress in cancer detection, molecular profiling, and precision therapies. We invite submissions that highlight pioneering breakthroughs in the following areas:
• Identification and Validation of Novel Biomarkers: Research focused on unearthing and validating new molecular biomarkers that can improve early detection, prognostic assessment, and therapeutic monitoring in diverse cancer types.
• Innovations in Molecular Profiling Approaches: Original findings and methodological advances in the development and optimization of molecular profiling tools utilizing multi-omics platforms, with emphasis on their utility in refining cancer classification and informing prognosis.
• Advances in Targeted Therapeutics: Studies detailing the design, engineering, and application of contemporary targeted therapy modalities—including PROTACs, immunotoxins, bispecific antibodies, and AI-driven drug discovery algorithms—aimed at enhancing treatment specificity and efficacy.
• Tumor Microenvironment and Therapeutic Resistance: Investigations into the dynamic interactions between tumor cells and their microenvironment, and the biological mechanisms that contribute to resistance against standard and targeted therapies.
• Translational Research and Clinical Implementation: Reports and reviews that bridge the gap from molecular discovery to clinical application, including case studies highlighting successful technology transfer, the design of cutting-edge clinical trials, and insights on improving patient outcomes.
By combining cutting-edge research and expert insights, this Research Topic aims to promote interdisciplinary collaboration and advance the clinical application of molecular bioscience discoveries in oncology. We invite original research articles, reviews, technology and methods papers, and clinical studies that collectively support our goal of achieving precision medicine in cancer treatment.
Article types and fees
This Research Topic accepts the following article types, unless otherwise specified in the Research Topic description:
Brief Research Report
Editorial
FAIR² Data
FAIR² DATA Direct Submission
General Commentary
Hypothesis and Theory
Methods
Mini Review
Opinion
Articles that are accepted for publication by our external editors following rigorous peer review incur a publishing fee charged to Authors, institutions, or funders.
Article types
This Research Topic accepts the following article types, unless otherwise specified in the Research Topic description:
Important note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
